Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

New study identifies potential targets for KRAS-related treatment resistance (opens in a new tab)

news-medical.net · 2026-10-29

Short answerEvidenceSource

Short answer

Not assessed

Check incomplete.

We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Source study identified.

A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.

View article claims
3
Then inspect each claim

Evidence layer

Claim by claim

A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.

Claim 1 of 6Not checkedScientists at St. Jude Children's Research Hospital identified how one factor involved in mRNA decoding can be altered, identifying potential cancer origins and new targets for KRAS-related treatment resistance.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 2 of 6Not checkedThe study says METTL13 modifies eEF1A at lysine 55, increasing protein synthesis and promoting tumor growth, and that the effect of eEF1A K55 methylation on translation elongation had been unknown.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 3 of 6Not checkedThe team found that the eEF1AK55me2-METTL13 axis promotes efficient translation of a subset of codons enriched in oncogenes such as KRAS.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 4 of 6Not checkedThe team examined METTL13 disruption as a potential target to overcome KRAS-related treatment resistance and observed stymied growth of KRAS-inhibitor-resistant tumors in animal models.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 5 of 6Not checkedIn healthy pre-clinical models, knocking out METTL13 did not cause toxic effects.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 6 of 6Not checkedThe researchers also reported that increased METTL13 activity correlated with poor prognosis in patients with lung adenocarcinoma and pancreatic ductal adenocarcinoma.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Methylated eEF1A selectively decodes mRNA to shape cancer proteomes

Nature Cell Biology · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 41 candidate papers

And 35 more candidates considered.